Clinical data | |
---|---|
Other names | MER-104 |
Routes of administration | Subcutaneous injection [1] [2] |
Drug class | GnRH antagonist |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard ( EPA) | |
Chemical and physical data | |
Formula | C80H102ClN15O14 |
Molar mass | 1533.24 g·mol−1 |
3D model ( JSmol) | |
| |
|
Acyline (developmental code name MER-104) is a gonadotropin-releasing hormone analogue (GnRH analogue) and gonadotropin-releasing hormone antagonist (GnRH antagonist) which was never marketed. [1] [2] [3] It has been shown to suppress gonadotropin and testosterone levels in men. [1] [2] [3] Acyline is a peptide and under normal circumstances is not orally active. [3] For this reason, it has instead been administered by subcutaneous injection. [1] [2]